Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CA$4.88, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 16x in the Luxury industry in North America. Total returns to shareholders of 290% over the past three years. Recent Insider Transactions • Jun 10
President recently sold CA$4.5m worth of stock On the 5th of June, Hylton Karon sold around 1m shares on-market at roughly CA$3.70 per share. This transaction amounted to 6.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Hylton's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CA$4.13, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 16x in the Luxury industry in North America. Total returns to shareholders of 239% over the past three years. New Risk • Jun 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (60% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (17% average weekly change). Shareholders have been diluted in the past year (21% increase in shares outstanding). New Risk • May 13
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (60% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (17% average weekly change). Market cap is less than US$100m (CA$125.1m market cap, or US$91.3m). Announcement • Apr 28
iFabric Corp., Annual General Meeting, Jun 29, 2026 iFabric Corp., Annual General Meeting, Jun 29, 2026. Location: ontario, markham Canada Reported Earnings • Apr 02
Full year 2025 earnings released: CA$0.003 loss per share (vs CA$0.054 profit in FY 2024) Full year 2025 results: CA$0.003 loss per share (down from CA$0.054 profit in FY 2024). Revenue: CA$32.9m (up 20% from FY 2024). Net loss: CA$99.2k (down 106% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 17
Investor sentiment improves as stock rises 37% After last week's 37% share price gain to CA$2.99, the stock trades at a trailing P/E ratio of 57.6x. Average trailing P/E is 22x in the Luxury industry in North America. Total returns to shareholders of 256% over the past three years. New Risk • Mar 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 16% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (CA$67.3m market cap, or US$49.2m). Valuation Update With 7 Day Price Move • Jan 30
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CA$2.20, the stock trades at a trailing P/E ratio of 42.4x. Average trailing P/E is 22x in the Luxury industry in North America. Total returns to shareholders of 137% over the past three years. Valuation Update With 7 Day Price Move • Jan 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CA$1.84, the stock trades at a trailing P/E ratio of 35.4x. Average trailing P/E is 22x in the Luxury industry in North America. Total returns to shareholders of 127% over the past three years. Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to CA$1.69, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 24x in the Luxury industry in North America. Total returns to shareholders of 141% over the past three years. Reported Earnings • Nov 15
Third quarter 2025 earnings released: EPS: CA$0.018 (vs CA$0.003 loss in 3Q 2024) Third quarter 2025 results: EPS: CA$0.018 (up from CA$0.003 loss in 3Q 2024). Revenue: CA$9.02m (up 111% from 3Q 2024). Net income: CA$543.8k (up CA$649.4k from 3Q 2024). Profit margin: 6.0% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. New Risk • Nov 15
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 31% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (CA$36.7m market cap, or US$26.1m). Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CA$1.32, the stock trades at a trailing P/E ratio of 43.3x. Average trailing P/E is 19x in the Luxury industry in North America. Total returns to shareholders of 91% over the past three years. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CA$1.29, the stock trades at a trailing P/E ratio of 42.3x. Average trailing P/E is 21x in the Luxury industry in North America. Total returns to shareholders of 30% over the past three years. Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CA$1.05, the stock trades at a trailing P/E ratio of 34.4x. Average trailing P/E is 19x in the Luxury industry in North America. Total loss to shareholders of 20% over the past three years. Announcement • Aug 22
iFabric Corp. Announces Publication of Groundbreaking Clinical Trial Providing the Infection Convenience Capability of PROTX2 and ecoPEL Treated Scrubs iFabric Corp. announced that the results of its clinical trial, "Antimicrobial-treated fabric scrubs can prevent pathogen proliferation on scrubs, has been officially published in the Journal of Hospital Infection, the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience. The study-conducted by subsidiary Intelligent Fabric Technologies (North America) Inc. "IFTNA" at MemorialCare Saddleback Medical Center in Southern California under the leadership of Cheryl Westlake, PhD, RN, ACNS-BC, FHFSA, FAHA, FAAN;leen M. Young, MSN, RN, NPD-BC;andi Cassingham, MSN, RN; and Lisa Forsythe, MSN-Ed, RN, NPD- BC-marks the first successful antimicrobial textile trial of its kind to demonstrate statistically significant reductions in bacterial loads on scrubs worn in a real-world healthcare setting. This trial conclusively showed that scrubs treated with PROTX2 and PROTX2 combined with ecoPEL Fluorine-Free Durable Water Repellent (DWR) technology achieved significant and quantifiable reductions in surface bacterial contamination compared to untreated scrubs -proof that these proprietary technologies can deliver infection control performance unmatched in the industry. As a nonprofit, all revenue is reinvested into patient care, technology, and facility improvements, supported by the Saddleback Medical Center Foundation, which has fostered community partnership and philanthropy since founding. With over 500 affiliated clinicians, the company provide a full spectrum of inpatient, surgical, and outpatient services-including urgent care, advanced imaging, joint replacement, infusion therapy, stroke care, and rehabilitation-ensuring accessible, high-quality care for every stage of life. At Saddleback Medical Center, compassionate care, medical excellence, and community partnership remain at the heart of its mission. Reported Earnings • Aug 15
Second quarter 2025 earnings released: CA$0.006 loss per share (vs CA$0.002 profit in 2Q 2024) Second quarter 2025 results: CA$0.006 loss per share (down from CA$0.002 profit in 2Q 2024). Revenue: CA$5.80m (flat on 2Q 2024). Net loss: CA$190.1k (down 439% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • May 16
First quarter 2025 earnings released: EPS: CA$0.003 (vs CA$0.018 in 1Q 2024) First quarter 2025 results: EPS: CA$0.003 (down from CA$0.018 in 1Q 2024). Revenue: CA$7.08m (up 4.8% from 1Q 2024). Net income: CA$88.5k (down 84% from 1Q 2024). Profit margin: 1.2% (down from 8.2% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings. Announcement • May 08
iFabric Corp. to Report Q1, 2025 Results on May 15, 2025 iFabric Corp. announced that they will report Q1, 2025 results Pre-Market on May 15, 2025 Announcement • Apr 23
iFabric Corp., Annual General Meeting, Jun 24, 2025 iFabric Corp., Annual General Meeting, Jun 24, 2025. Location: ontario, markham Canada Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CA$1.06, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 14x in the Luxury industry in North America. Total loss to shareholders of 66% over the past three years. Reported Earnings • Apr 01
Full year 2024 earnings released: EPS: CA$0.054 (vs CA$0.056 loss in FY 2023) Full year 2024 results: EPS: CA$0.054 (up from CA$0.056 loss in FY 2023). Revenue: CA$27.3m (up 20% from FY 2023). Net income: CA$1.63m (up CA$3.32m from FY 2023). Profit margin: 6.0% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Board Change • Mar 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Non-Executive Director Rich Macary was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 17
Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 3Q 2023) Third quarter 2024 results: CA$0.003 loss per share (improved from CA$0.005 loss in 3Q 2023). Revenue: CA$4.28m (down 11% from 3Q 2023). Net loss: CA$105.6k (loss narrowed 24% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance. New Risk • Aug 15
New major risk - Revenue and earnings growth Earnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.2% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CA$35.5m market cap, or US$25.9m). Reported Earnings • Aug 15
Second quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.004 in 2Q 2023) Second quarter 2024 results: EPS: CA$0.002 (down from CA$0.004 in 2Q 2023). Revenue: CA$5.80m (up 9.8% from 2Q 2023). Net income: CA$56.1k (down 58% from 2Q 2023). Profit margin: 1.0% (down from 2.5% in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Reported Earnings • May 15
First quarter 2024 earnings released: EPS: CA$0.018 (vs CA$0.015 in 1Q 2023) First quarter 2024 results: EPS: CA$0.018 (up from CA$0.015 in 1Q 2023). Revenue: CA$6.75m (up 1.7% from 1Q 2023). Net income: CA$550.6k (up 17% from 1Q 2023). Profit margin: 8.2% (up from 7.1% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Apr 03
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 7.0% to CA$1.23. The fair value is estimated to be CA$1.02, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Apr 02
Full year 2023 earnings released: CA$0.07 loss per share (vs CA$0.015 loss in FY 2022) Full year 2023 results: CA$0.07 loss per share (further deteriorated from CA$0.015 loss in FY 2022). Revenue: CA$28.4m (up 44% from FY 2022). Net loss: CA$2.11m (loss widened 363% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance. Announcement • Mar 14
iFabric Corp. Provides Sales Guidance for the Full Year 2024 iFabric Corp. provided Sales guidance for the full year 2024. For the year, the company expects sales to the range of $28 million to $32 million. Valuation Update With 7 Day Price Move • Mar 13
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CA$1.26, the stock trades at a trailing P/E ratio of 64x. Average trailing P/E is 18x in the Luxury industry in North America. Total loss to shareholders of 76% over the past three years. Valuation Update With 7 Day Price Move • Feb 19
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CA$1.01, the stock trades at a trailing P/E ratio of 51.3x. Average trailing P/E is 20x in the Luxury industry in North America. Total loss to shareholders of 80% over the past three years. Announcement • Nov 10
iFabric Corp. Announces Expansion Move iFabric Corp. announced that it has executed a lease agreement for the rental of approximately 5,000 square feet of office space in Markham, Ontario, at a commercial office building near its current head office and warehouse location. The new offices will house the Canadian management and administrative personnel of the Company. After the move, the current Company owned building located at 525 Denison Street, Markham, Ontario, which currently comprises a mix of warehouse and office space, will be fully repurposed as warehouse space. The new office lease agreement is for a period of 5 years commencing on April 1, 2024, and expiring March 31, 2029, with the option to renew for a further period of 5 years. iFabric's personnel will be occupying temporary space at the new location, until such time as the required leasehold improvements to its new premises have been completed. Reported Earnings • Aug 15
Third quarter 2023 earnings released: EPS: CA$0.004 (vs CA$0.012 in 3Q 2022) Third quarter 2023 results: EPS: CA$0.004 (down from CA$0.012 in 3Q 2022). Revenue: CA$5.28m (flat on 3Q 2022). Net income: CA$132.5k (down 62% from 3Q 2022). Profit margin: 2.5% (down from 6.6% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings. Announcement • Jul 06
iFabric Corp. Announces the Successful Results of the Clinical Trial Utilizing Protx2 Treated Scrubs iFabric Corp. provided an update on the outcome of the clinical trial conducted by its wholly-owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"). The objective of the trial was to empirically demonstrate the reduction in bacterial loads on PROTX2 treated scrubs vs standard off the shelf untreated scrubs, when used in a healthcare environment. Three sets of scrubs were produced for the trial; one set treated with ProTX2 only, a second set with Protx2 and proprietary DWR (durable water repellant) technology and, a third set with no technologies applied (the control). The summary of the trial findings is that both the PROTX2 and the PROTX2 with DWR treated scrubs demonstrated statistically significant reductions in bacterial loads on the surfaces of scrubs, as compared to untreated scrubs. The term statistically significant is used to describe a result that is highly unlikely to occur by chance alone in a natural environment. The results achieved in the study demonstrate that proprietary technologies were uniquely responsible for the reduction in bacterial loads witnessed throughout the trial. The next and final phase of this trial is to submit the study to a recognized medical journal for peer review. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CA$1.50, the stock trades at a trailing P/E ratio of 69.6x. Average trailing P/E is 14x in the Luxury industry in North America. Total loss to shareholders of 70% over the past three years. Valuation Update With 7 Day Price Move • May 25
Investor sentiment improves as stock rises 39% After last week's 39% share price gain to CA$1.53, the stock trades at a trailing P/E ratio of 71x. Average trailing P/E is 12x in the Luxury industry in North America. Total loss to shareholders of 65% over the past three years. Reported Earnings • May 19
Second quarter 2023 earnings released: EPS: CA$0.015 (vs CA$0.023 loss in 2Q 2022) Second quarter 2023 results: EPS: CA$0.015 (up from CA$0.023 loss in 2Q 2022). Revenue: CA$6.64m (up 91% from 2Q 2022). Net income: CA$469.4k (up CA$1.14m from 2Q 2022). Profit margin: 7.1% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 14
First quarter 2023 earnings released: EPS: CA$0.005 (vs CA$0.006 in 1Q 2022) First quarter 2023 results: EPS: CA$0.005 (down from CA$0.006 in 1Q 2022). Revenue: CA$4.92m (down 1.6% from 1Q 2022). Net income: CA$134.6k (down 20% from 1Q 2022). Profit margin: 2.7% (down from 3.4% in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Announcement • Jan 28
iFabric Corp., Annual General Meeting, Mar 30, 2023 iFabric Corp., Annual General Meeting, Mar 30, 2023. Recent Insider Transactions Derivative • Jan 12
Key Executive exercised options to buy CA$324k worth of stock. On the 3rd of January, Hilton Price exercised options to buy 400k shares at a strike price of around CA$0.40, costing a total of CA$160k. This transaction amounted to 71% of their direct individual holding at the time of the trade. Since March 2022, Hilton's direct individual holding has increased from 462.50k shares to 562.50k. Company insiders have collectively bought CA$219k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Dec 29
Full year 2022 earnings released: CA$0.015 loss per share (vs CA$0.084 profit in FY 2021) Full year 2022 results: CA$0.015 loss per share (down from CA$0.084 profit in FY 2021). Revenue: CA$19.7m (flat on FY 2021). Net loss: CA$455.0k (down 119% from profit in FY 2021). Announcement • Oct 28
iFabric Corp. Announces Launch of Verzus All Apparel Brand and New Orders iFabric Corp. provided an update on the Company's new brand launch and new orders for its swimwear products. The brand was developed to showcase the dynamic range of class-leading fabric technologies, applied to premium and luxury fabrics. The VERZUS ALL range of products was designed by in-house design team and is manufactured by production partners in Asia. VERZUS ALL products are being marketed on-line at newly launched website as well as through first company-branded retail location - at the 140-store Markville Shopping Centre near to head offices in Markham, Ontario, Canada. Such direct-to-consumer sales provide the highest margin point for iFabric products. Reported Earnings • Aug 12
Third quarter 2022 earnings released: EPS: CA$0.012 (vs CA$0.024 in 3Q 2021) Third quarter 2022 results: EPS: CA$0.012 (down from CA$0.024 in 3Q 2021). Revenue: CA$5.24m (up 26% from 3Q 2021). Net income: CA$344.8k (down 51% from 3Q 2021). Profit margin: 6.6% (down from 17% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 13
Second quarter 2022 earnings released: CA$0.023 loss per share (vs CA$0.005 loss in 2Q 2021) Second quarter 2022 results: CA$0.023 loss per share (down from CA$0.005 loss in 2Q 2021). Revenue: CA$3.48m (up 21% from 2Q 2021). Net loss: CA$671.7k (loss widened 376% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 22
Investor sentiment deteriorated over the past week After last week's 25% share price decline to CA$2.40, the stock trades at a trailing P/E ratio of 76x. Average trailing P/E is 12x in the Luxury industry in North America. Total returns to shareholders of 116% over the past three years. Reported Earnings • Feb 15
First quarter 2022 earnings: Revenues and EPS in line with analyst expectations First quarter 2022 results: EPS: CA$0.006 (down from CA$0.06 in 1Q 2021). Revenue: CA$4.99m (down 34% from 1Q 2021). Net income: CA$168.0k (down 90% from 1Q 2021). Profit margin: 3.4% (down from 21% in 1Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Announcement • Feb 09
iFabric Corp. Announces Board Changes iFabric Corp. announced the appointment of Rich Macary as a director. Mr. Macary is the current Chief Strategy Officer of Delos Living LLC ("Delos") and former President of Delos Ventures. Rich provides Delos, a wellness real estate and technology company, with senior level business development skills and a wealth of relevant experience on key value driving areas including business development, product innovation, concept/IP licensing, strategic partnerships, collaborations and joint ventures. Prior to joining Delos, Rich was Vice President of Business Development for Sarepta Therapeutics, a leader in RNA based therapies targeting rare and infectious diseases. Rich spent the prior 20 years as a corporate consultant, advisor and analyst to both institutional and high-net-worth investors as well as a consultant, advisor, investor and board member to several public and private early to mid-stage companies operating in a diverse range of industries including technology, biotechnology, medical devices, health &wellness, real estate,retail concepts and consumer products among others. In connection with Mr. Macary's appointment, the company also announced that Mr. Mark Greenspan is retiring and is stepping down as a director. The board of directors would like to thank Mr. Greenspan for his contributions to the Company. Mr. Greenspan has added significant value to the Company since joining the board in 2011 and will be greatly missed for his contribution to the both the board and the audit committee. The board of directors remains at six directors serving on iFabric's board, including three independent, non-executive directors. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improved over the past week After last week's 18% share price gain to CA$3.05, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 17x in the Luxury industry in North America. Total returns to shareholders of 118% over the past three years. Reported Earnings • Dec 31
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: CA$0.084 (up from CA$0.023 loss in FY 2020). Revenue: CA$19.8m (up 72% from FY 2020). Net income: CA$2.37m (up CA$2.99m from FY 2020). Profit margin: 12% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Nov 02
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CA$2.40, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 23x in the Luxury industry in North America. Total returns to shareholders of 43% over the past three years. Reported Earnings • Aug 13
Third quarter 2021 earnings released: EPS CA$0.024 (vs CA$0.021 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CA$4.16m (up 29% from 3Q 2020). Net income: CA$705.4k (up CA$1.25m from 3Q 2020). Profit margin: 17% (up from net loss in 3Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year whereas the company’s share price has increased by 25% per year. Reported Earnings • May 14
Second quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.018 loss in 2Q 2020) The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$2.88m (up 28% from 2Q 2020). Net loss: CA$141.2k (loss narrowed 71% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Announcement • Feb 23
iFabric Corp. announced that it has received CAD 11.499996 million in funding On February 22, 2021, iFabric Corp. (TSX:IFA) closed the transaction. The company issued a total of 2,948,717 subscription receipts for gross proceeds of approximately CAD 11,500,000. The full exercise of the agents' option was granted to the agents in connection with the offering. Announcement • Feb 13
iFabric Corp. Engages Independent Trading Group (ITG) Inc. for Market Making Services iFabric Corp. announced that it has engaged Independent Trading Group (ITG) Inc. provide market-making services on the Toronto Stock Exchange ("TSX") and other marketplaces, as applicable, in compliance with the policies and guidelines of the TSX and other applicable regulation. The objective is to maintain a reasonable market and improve the liquidity of the Common Shares. Pursuant to the terms of a services agreement (the "Services Agreement"), ITG will receive compensation of CAD 6,000 per month (plus applicable taxes), payable on the first business day of each month, for an initial term of three months (the "Initial Term"), with services commencing on February 12, 2021. The Services Agreement will renew for subsequent one (1) month terms (each,an "Additional Term") unless either party provides at least thirty (30) days written notice prior to the end of the Initial Term or an Additional Term, as applicable. The Services Agreement may be terminated by either party with 30 days' notice. Reported Earnings • Feb 12
First quarter 2021 earnings released: EPS CA$0.06 (vs CA$0.002 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CA$7.52m (up 190% from 1Q 2020). Net income: CA$1.60m (up CA$1.55m from 1Q 2020). Profit margin: 21% (up from 2.1% in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 72% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Announcement • Feb 02
Ifabric Corp. Announces Maidenform License Renewal iFabric Corp. announced that its wholly owned subsidiary company, Coconut Grove Pads Inc., has renewed its license and distribution agreement with MFB International Holdings S.a.r.l. The agreement covers the distribution by CGP of intimate apparel accessories and specialty bra solutions which are marketed under Hanes' various Maidenform brands. Under the terms of the agreement the Company has the non-exclusive right to use trademarks in connection with the manufacture, marketing, sale and distribution of various Maidenform® branded products, in the Company's market segment in certain countries including, among others, the United States, Canada, Mexico, the United Kingdom and a number of Caribbean countries. During the license term, the Company is required to pay a quarterly royalty on its net sales as defined in the agreement, on all products sold under the licensed marks. The effective royalty rates vary depending on the distribution channel and range from 0%-10%. Minimum annual royalties have been established for the period ending December 31, 2021 at USD 122,500. In addition, the Company is required to pay an advertising fee of 1%-2%, depending on the distribution channel. The license term is in effect until December 31, 2021. Is New 90 Day High Low • Jan 29
New 90-day high: CA$5.00 The company is up 43% from its price of CA$3.49 on 30 October 2020. The Canadian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 13% over the same period. Announcement • Jan 23
iFabric Corp., Annual General Meeting, Mar 31, 2021 iFabric Corp., Annual General Meeting, Mar 31, 2021. Is New 90 Day High Low • Jan 09
New 90-day high: CA$4.32 The company is up 4.0% from its price of CA$4.15 on 09 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Luxury industry, which is also up 4.0% over the same period. Reported Earnings • Dec 25
Full year 2020 earnings released: CA$0.023 loss per share The company reported a solid full year result with reduced losses and improved revenues and control over expenses. Full year 2020 results: Revenue: CA$11.5m (up 10% from FY 2019). Net loss: CA$617.8k (loss narrowed 53% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 93% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Oct 17
New 90-day low: CA$3.75 The company is down 29% from its price of CA$5.29 on 17 July 2020. The Canadian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Luxury industry, which is up 31% over the same period. Announcement • Sep 18
Ifabric Corp. Finalized a Five Year Exclusive Agreement with Beverly Hills Investments (Pty) Ltd iFabric Corp. announced that its Intelligent Fabric Technologies Division has finalized a five year exclusive agreement with Beverly Hills Investments (Pty) Ltd. to sell and distribute ProTX2 formulations and products containing anti-microbial and anti-viral formulations throughout the continent of Africa. The agreement requires minimum annual purchases of USD 2 million, USD 4 million, and USD 12 million for years 1, 2, and 3 respectively. 
